The rapid and vast growth of the biopharmaceutical industry necessitates, for Canada, increased intellectual property protection in order to keep up with competitors in the pharmaceutical market.
Read Laura's full article here.
Author
Laura Dawson
Former Fellow and Former Director, Canada Institute;
Executive Director, Future Borders Coalition
Executive Director, Future Borders Coalition
Canada Institute
The mission of the Wilson Center's Canada Institute is to raise the level of knowledge of Canada in the United States, particularly within the Washington, DC policy community. Research projects, initiatives, podcasts, and publications cover contemporary Canada, US-Canadian relations, North American political economy, and Canada's global role as it intersects with US national interests. Read more
Explore More
Browse Insights & Analysis
Understanding Trade Promotion Authority (TPA): Implications for US Trade
Posted date/time:
The Innovative Landscape of African Sovereign Wealth Funds
Posted date/time:
A Case for a North American Common Tariff
Posted date/time: